Abstract Details
|
Claudio M. De Gusmao, MD
PRESENTER |
Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mendelics Genomic Analysis. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving as a Consultant for EBSCO publishing. Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Outcome Solutions. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeuthics. The institution of Dr. DeGusmao has received research support from FDA. |
| Richard J. Barohn, MD, FAAN (University of Missouri) | Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care. |
| Nutan Sharma, MD, PhD, FAAN (Massachusetts General Hospital) | Dr. Sharma has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Laurie J. Ozelius, PhD | The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care. |